Tag archive for ‘BL-8040 drug’
CEO biolinerx
Jewish Business News Service On Monday, December 16th, 2013

Israeli BioLineRx Announces Promising Initial Phase 2 Results of Acute Myeloid Leukemia Treatment

– Initial results for BL-8040 show substantial mobilization of cancer cells and signs of robust cancer cell death (apoptosis) –  CEO Kinneret Savitsky – BioLineRx (NASDAQ: BLRX; TASE: BLRX), More...

Wordpress site Developed by Fixing WordPress Problems